VERGONI, Anna Valeria
 Distribuzione geografica
Continente #
NA - Nord America 7.598
AS - Asia 3.504
EU - Europa 3.062
SA - Sud America 530
AF - Africa 73
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.786
Nazione #
US - Stati Uniti d'America 7.508
GB - Regno Unito 1.330
SG - Singapore 1.052
CN - Cina 1.031
HK - Hong Kong 454
BR - Brasile 419
SE - Svezia 401
VN - Vietnam 382
IT - Italia 314
DE - Germania 201
RU - Federazione Russa 173
UA - Ucraina 162
FI - Finlandia 143
TR - Turchia 142
FR - Francia 103
KR - Corea 99
IN - India 65
BG - Bulgaria 62
BD - Bangladesh 41
AR - Argentina 37
CA - Canada 35
MX - Messico 35
IQ - Iraq 34
ID - Indonesia 31
LT - Lituania 30
ZA - Sudafrica 27
JP - Giappone 23
NL - Olanda 23
AE - Emirati Arabi Uniti 22
IE - Irlanda 22
ES - Italia 19
BE - Belgio 18
RO - Romania 17
VE - Venezuela 17
AU - Australia 15
CL - Cile 15
EC - Ecuador 15
MY - Malesia 15
PK - Pakistan 15
PL - Polonia 14
CO - Colombia 10
EG - Egitto 10
PH - Filippine 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
MA - Marocco 9
UZ - Uzbekistan 9
KE - Kenya 8
NP - Nepal 7
TW - Taiwan 7
JO - Giordania 6
CH - Svizzera 5
IR - Iran 5
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
AT - Austria 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
GR - Grecia 3
SV - El Salvador 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
Totale 14.781
Città #
Southend 1.015
Santa Clara 724
Singapore 614
Ashburn 600
Chandler 491
Fairfield 473
Hong Kong 442
Woodbridge 399
Jacksonville 327
Hefei 325
Houston 301
Ann Arbor 294
Chicago 262
Dallas 261
Nyköping 242
San Jose 218
Dearborn 211
Seattle 208
Wilmington 188
Los Angeles 172
Cambridge 166
Beijing 165
London 140
Ho Chi Minh City 126
Salt Lake City 103
The Dalles 99
Hanoi 94
Seoul 89
Modena 87
Izmir 76
Helsinki 74
Council Bluffs 70
Moscow 63
Princeton 63
Sofia 60
New York 58
Eugene 56
San Diego 54
Shanghai 50
Elk Grove Village 49
Lauterbourg 48
Tampa 40
Buffalo 36
São Paulo 35
Orem 30
Redwood City 30
Des Moines 28
Bremen 27
Columbus 27
Milan 25
Munich 25
Dublin 21
Haiphong 21
Lancaster 21
Fremont 20
Falls Church 19
Tokyo 18
Guangzhou 17
Brussels 16
Chennai 16
Frankfurt am Main 16
Rio de Janeiro 16
Sterling 16
Baghdad 15
Boardman 15
Detroit 15
Jakarta 14
Nanjing 14
Phoenix 14
Atlanta 13
Da Nang 13
Dulles 13
Norwalk 12
Stockholm 12
Turku 12
Mexico City 11
Miami 11
Brooklyn 10
Johannesburg 10
Kansas City 10
Kent 10
Kunming 10
Philadelphia 10
Pittsburgh 10
Toronto 10
Belo Horizonte 9
Denver 9
Paris 9
San Mateo 9
Sydney 9
Tashkent 9
Amsterdam 8
Baku 8
Hounslow 8
Kilburn 8
Mumbai 8
Rome 8
Verona 8
Warsaw 8
Auburn Hills 7
Totale 10.466
Nome #
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 484
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 464
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 404
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 393
Similarities and differences between chronic migraine and episodic migraine 375
Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. 372
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 341
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 318
Neuroprotective effect of L-DOPA co-administered with the adenosine A(2A) receptor agonist CGS 21680 in an animal model of Parkinson's disease 307
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 295
Afferent vagal fibres and central cholinergic mechanisms are involved in the TRH-induced reversal of haemorrhagic shock 291
Brain effects of melanocortins 289
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormons involved in food intake and metabolism: insulin and melanocortins 286
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 280
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 279
Cholecystokinin peptides and bombesin reverse hemorrhagic shock in rats 273
Effect of repeated administration of prolactin releasing peptide on feeding behavior in rats 268
Health risk assessment of environmental selenium: Emerging evidence and challenges (Review) 268
INFLUENCE OF ACTH-(1-24) ON INGESTIVE BEHAVIOURS 264
Anatomia chimica e funzionale dei sistemi peptidergici. 260
Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract 258
BRAIN ACETYLCHOLINE IS INVOLVED IN THE ACTH-INDUCED BEHAVIORAL SYNDROME IN RATS 257
Engineered polylactide-co-glycolide(PLGA) Np as drug delivery systems for the Central Nervous System 253
Putrescine has antiarrhythmic effects in rat models of arrhythmia. 250
Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of BBB crossing 241
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 240
Polymeric nanoparticles for CNS drug delivery: strategies and perspectives 240
Energy gradients for VT-signal migration in the CNS: studies on melanocortin receptors, mitochondrial uncoupling proteins and food intake 238
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 236
Brain MC4 receptors are involved in the melanocortin-induced hemorrhagic shock reversal, in rats 235
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 231
Sistemi anti-analgesici endogeni 231
Influence of clonidine on the ACTH-induced behavioral syndrome 229
Peptide-decorated nanoparticles as carriers for drug delivery to CNS 228
Surface decorated nanoparticles as drug delivery agents to the brain 228
Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet 228
NPY-induced inhibition of male copulatory acivity is a direct behavioural effect 226
Modified PLGA Nanoparticles as drug carriers for CNS delivery 226
A 7-DAY I.V.C. INFUSION OF ACTH-(1-24), IN RATS, IS ASSOCIATED WITH THE DEVELOPMENT OF TOLERANCE TO ITS BEHAVIOURAL EFFECTS AND WITH INCREASED LEVELS OF HYPOTHALAMIC B-ENDORPHIN 224
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: Part 2: Effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring 224
Nanoparticelle polimeriche per il direzionamento di farmaci al Sistema Nervoso Centrale 222
Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease 219
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 219
Mechanism of action of the anti-shock effect of CCK-8: influence of CCK antagonists and of sympatholytic drugs 216
Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides 216
Leptin-conjugated nanoparticles as drug delivery system to the brain 215
Anti-shock effect of CCK-8 mechanis of action 214
Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat 213
Effetti periferici degli oppioidi 213
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 209
Peptide-derivatized nanoparticles as carriers of drugs into the central nervous system 203
Evidence that melanocortins are physiological antagonists of opioids 201
Anti-shock effect of ACTH-(1-24): comparison between intracerebroventricular and intravenous route of administration 197
Endogenous antagonists of opioid peptides 192
Functional role, structure, and evolution of the melanocortin-4 receptor 191
Nanoparticles and Brain Targeting 151
Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats 149
Inhibition of feeding by ACTH-(1-24): behavioral and pharmacological aspects 128
LACK OF INFLUENCE OF AROMATASE AND 5-ALPHA-REDUCTASE INHIBITION ON [H-3] IMIPRAMINE BINDING IN THE MALE-RAT BRAIN 3
PINACIDIL POTENTIATES MORPHINE ANALGESIA 2
l-Sulpiride, at a low, non neuroleptic dose, prevents conditioned fear stress induced freezing behavior in rats 2
OPENING OF BRAIN POTASSIUM-CHANNELS INHIBITS THE ACTH-INDUCED BEHAVIORAL SYNDROME IN THE MALE-RAT 1
REPEATED ADMINISTRATION OF TRIIODOTHYRONINE ENHANCES THE SUSCEPTIBILITY OF RATS TO ISONIAZID-INDUCED AND PICROTOXIN-INDUCED SEIZURES 1
EFFECTS OF THYROID STATUS ON THE CHARACTERISTICS OF ALPHA1-IMIPRAMINE, ALPHA2-IMIPRAMINE, BETA-IMIPRAMINE IMIPRAMINE AND GABA RECEPTORS IN THE RAT-BRAIN 1
INFLUENCE OF GONADOTROPIN-RELEASING-HORMONE ON CASTRATION-INDUCED DEPRESSION IN MICE - A BEHAVIORAL AND BINDING STUDY 1
INFLUENCE OF THE SELECTIVE CHOLECYSTOKININ ANTAGONIST L-364,718 ON PAIN THRESHOLD AND MORPHINE ANALGESIA 1
NO MODIFICATIONS OF GABA(A) AND BENZODIAZEPINE RECEPTORS FOLLOWING EXPERIMENTAL DYSTHYROIDISM IN RATS 1
Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage. 1
Behavioral effects of atriopeptin in rats. 1
Melanocortins and feeding behavior 1
CHRONIC ADMINISTRATION OF I-SULPIRIDE AT NON-NEUROLEPTIC DOSES REDUCES THE DURATION OF IMMOBILITY IN EXPERIMENTAL-MODELS OF DEPRESSION-LIKE BEHAVIOR 1
Totale 14.819
Categoria #
all - tutte 54.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 0 0 0 0 190 73 40
2021/2022983 27 141 86 73 29 45 49 34 107 57 212 123
2022/20231.215 159 164 84 128 150 193 24 96 130 9 37 41
2023/2024666 25 42 52 44 139 50 85 83 23 15 63 45
2024/20252.622 92 20 42 184 526 360 276 150 270 95 278 329
2025/20264.820 325 212 551 630 1.135 329 510 216 533 379 0 0
Totale 14.819